Notes on the Role of Intestinal Microbiota in Obesity

The human large intestine contains a complex community of microorganisms known as the microbiota.
These microorganisms affect various aspects of physiology and health.
There is evidence from rodent models suggesting that the intestinal microbiota may influence obesity development.

Study demonstrates that intestinal microbiota from lean humans can protect against fat gain in experimental mice.
Study involved transferring fecal samples from four female twin pairs discordant for obesity into germ-free mice.
Mice receiving transplants from obese (Ob) twin donors developed increased adiposity, while those receiving lean (Ln) twin samples remained lean.
The results indicate the correlation between the type of intestinal microbiota and the adiposity phenotype of the recipient mice.

Germ-free mice inoculated with microbiota from an obese (Obch) twin did not transmit their adiposity phenotype to mice carrying microbiota from a lean (Lnch) twin.
Cohousing allowed for successful colonization of Obch intestines by Lnch bacteria, which prevented increased adiposity in Obch mice.
By contrast, Obch microbiota did not effectively colonize the Lnch mice, who remained lean.

Analysis showed that members of the Bacteroidetes phylum, specifically Bacteroides spp., were associated with protection against increased adiposity.
Attempts to use a simplified collection of bacterial strains (39 defined strains) did not yield a reduction in adiposity in Obch mice, indicating the need for complex bacterial interactions for effective weight management.

Diet is crucial in determining the transmissibility of microbiota and the host's adiposity phenotype.
When Obch mice were fed a low-fat, high-fiber diet, lean-derived bacterial strains colonized and ameliorated excess adiposity.
Conversely, a high-fat, low-fiber diet inhibited the beneficial effects of lean microbiota transplantation.

The primary function of intestinal microbiota is to break down dietary fibers into short-chain fatty acids (SCFAs): acetate, propionate, and butyrate.
The host absorbs these SCFAs, contributing approximately 5-10% of daily energy requirements.
Ridaura et al. found that lean mice produced greater amounts of SCFAs and digested more plant fiber compared to obese mice.
SCFAs inhibit adiposity by:
- Preventing fat accumulation in adipose tissue
- Raising energy expenditure
- Enhancing production of hormones related to satiety.

Intestinal microbiota may also play roles in metabolizing bile acids, branched-chain amino acids, and acylcarnitines, which have links to insulin resistance and obesity.

The efficacy of translating findings to humans remains uncertain.
Although Bacteroides species are correlated with reduced adiposity in mouse models, human studies present mixed results.
Further investigations are required to clarify the implications of beneficial microbial activity in humans, particularly considering differences in diet and obesity trends among populations.

Microbial protection against obesity requires an appropriate diet for effective colonization of beneficial microbes.
Potential therapies aiming at obesity may involve dietary changes in conjunction with microbial transplantations.
Fecal transplants are already being explored to modify microbiota for various medical conditions.
Recent studies indicate promising results where fecal transplants from lean individuals to obese counterparts improved insulin sensitivity.
However, fecal transplants come with risks, including potential pathogen transmission.
Ridaura et al.'s mouse model serves as a timely opportunity for controlled testing of human-derived bacteria and dietary regimens.
The ultimate goal is developing simplified bacterial mixtures as potential anti-obesity therapeutics.

Walker, A. W., Lawley, T. D. (2013). Pharmacological Research, 69, 75.
Ridaura, V. K. et al. (2013). Science, 341, 1241214. DOI: 10.1126/science.1241214.
Hooper, L. V., Midtvedt, T., Gordon, J. I. (2002). Annual Review of Nutrition, 22, 283.
Kimura, I. et al. (2013). Nature Communications, 4, 1829.
Gao, Z. et al. (2009). Diabetes, 58, 1509.
Keenan, M. J. et al. (2006). Obesity (Silver Spring), 14, 1523.
Turnbaugh, P. J. et al. (2006). Nature, 444, 1027.
Duncan, S. H. et al. (2008). International Journal of Obesity, 32, 1720.
Schwiertz, A. et al. (2010). Obesity (Silver Spring), 18, 190.
Wu, G. D. et al. (2011). Science, 334, 105.
De Filippo, C. et al. (2010). Proceedings of the National Academy of Sciences U.S.A, 107, 14691.
van Nood, E. et al. (2013). New England Journal of Medicine, 368, 407.
Vrieze, A. et al. (2012). Gastroenterology, 143, 913e7.